| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| β二酮类产品(元) | 75,540,237.38 | 174,204,658.63 | 98,781,509.49 | 174,360,262.38 | 93,293,470.11 |
| 硬脂酸盐类产品(元) | 146,427,758.71 | 348,183,192.51 | 169,862,675.32 | 340,037,776.33 | 160,729,473.67 |
| 苯乙酮产品(元) | 21,056,088.58 | 42,790,158.76 | 24,503,176.18 | 18,908,158.34 | - |
| IM002产品(元) | 18,265,486.80 | - | - | - | - |
| 调试产品(元) | 5,058,419.45 | - | - | - | - |
| 营业成本(元) | |||||
| β二酮类产品(元) | 58,059,998.92 | 131,206,559.74 | 70,648,050.54 | 118,103,947.79 | 61,487,291.66 |
| 硬脂酸盐类产品(元) | 132,367,434.71 | 323,675,240.70 | 155,739,521.45 | 317,008,879.04 | 145,901,747.82 |
| 苯乙酮产品(元) | 19,036,762.93 | 35,691,279.42 | 20,025,058.24 | 14,247,999.17 | - |
| IM002产品(元) | 13,507,201.92 | - | - | - | - |
| 调试产品(元) | 4,638,555.03 | - | - | - | - |
| 毛利(元) | |||||
| β二酮类产品(元) | 17,480,238.46 | 42,998,098.89 | 28,133,458.95 | 56,256,314.59 | 31,806,178.45 |
| 硬脂酸盐类产品(元) | 14,060,324.00 | 24,507,951.81 | 14,123,153.87 | 23,028,897.29 | 14,827,725.85 |
| 苯乙酮产品(元) | 2,019,325.65 | 7,098,879.34 | 4,478,117.94 | 4,660,159.17 | - |
| IM002产品(元) | 4,758,284.88 | - | - | - | - |
| 调试产品(元) | 419,864.42 | - | - | - | - |
| 毛利率(%) | |||||
| β二酮类产品(%) | 23.14 | 24.68 | 28.48 | 32.26 | 34.09 |
| 硬脂酸盐类产品(%) | 9.60 | 7.04 | 8.31 | 6.77 | 9.23 |
| 苯乙酮产品(%) | 9.59 | 16.59 | 18.28 | 24.65 | - |
| IM002产品(%) | 26.05 | - | - | - | - |
| 调试产品(%) | 8.30 | - | - | - | - |
| 收入构成(%) | |||||
| β二酮类产品(%) | 28.36 | 30.82 | 33.70 | 32.69 | 36.73 |
| 硬脂酸盐类产品(%) | 54.98 | 61.61 | 57.94 | 63.76 | 63.27 |
| 苯乙酮产品(%) | 7.91 | 7.57 | 8.36 | 3.55 | - |
| IM002产品(%) | 6.86 | - | - | - | - |
| 调试产品(%) | 1.90 | - | - | - | - |
| 毛利构成(%) | |||||
| β二酮类产品(%) | 45.12 | 57.63 | 60.20 | 67.02 | 68.20 |
| 硬脂酸盐类产品(%) | 36.30 | 32.85 | 30.22 | 27.43 | 31.80 |
| 苯乙酮产品(%) | 5.21 | 9.52 | 9.58 | 5.55 | - |
| IM002产品(%) | 12.28 | - | - | - | - |
| 调试产品(%) | 1.08 | - | - | - | - |